MEDINET Co., Ltd. (TYO:2370)
Japan flag Japan · Delayed Price · Currency is JPY
30.00
-1.00 (-3.23%)
May 12, 2025, 3:30 PM JST

MEDINET Company Description

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan.

Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.

The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions comprise personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions.

The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.

MEDINET Co., Ltd.
Country Japan
Founded 1995
Industry Biotechnology
Sector Healthcare
Employees 92
CEO Kanenao Kubushiro

Contact Details

Address:
TRC Center Building
Tokyo, 143-0006
Japan
Phone 81 3 6631 1201
Website medinet-inc.co.jp

Stock Details

Ticker Symbol 2370
Exchange Tokyo Stock Exchange
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency JPY
ISIN Number JP3920990003
SIC Code 8731

Key Executives

Name Position
Kanenao Kubushiro Chief Executive Officer